{"product_id":"exoseal-vascular-closure-device","title":"EXOSEAL Vascular Closure Device","description":"\u003ch2\u003eThe Problem with Conventional Femoral Closure\u003c\/h2\u003e\u003cp\u003ePost-procedural hemostasis at the femoral arteriotomy site remains a time-sensitive and complication-prone step in endovascular intervention. Manual compression is inconsistent, and many closure devices rely on intravascular components that can pose risks in calcified or small-caliber vessels — leaving clinicians to choose between speed and safety.\u003c\/p\u003e\u003ch2\u003eThe EXOSEAL Solution: Fully Extravascular, Fully Bioabsorbable\u003c\/h2\u003e\u003cp\u003eThe \u003cstrong\u003eEXOSEAL Vascular Closure Device\u003c\/strong\u003e eliminates the intravascular footprint entirely. It is the only fully extravascular, bioabsorbable plug closure system compatible with \u003cstrong\u003e5Fr, 6Fr, and 7Fr sheaths\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eThe EXOSEAL deploys a small \u003cstrong\u003epolyglycolic acid (PGA) plug\u003c\/strong\u003e precisely at the external surface of the arteriotomy, sealing the puncture site through a simple \u003cstrong\u003e3-step deployment sequence\u003c\/strong\u003e — no suture-mediated closure, no metal clips, and no intraluminal components. The PGA material resorbs completely via hydrolysis, releasing CO₂ and H₂O as metabolic byproducts within \u003cstrong\u003e60 to 90 days\u003c\/strong\u003e, leaving no permanent implant at the access site.\u003c\/p\u003e\u003ch2\u003eProduct Gallery\u003c\/h2\u003e\u003cp\u003e\u003cimg src=\"generation:\/\/9a6dcdd4-089e-41ff-b9c3-0b8c2f1f6b6e\" alt=\"EXOSEAL Vascular Closure Device kit flatlay with component callout labels\"\u003e\u003c\/p\u003e\u003cp\u003e\u003cimg src=\"generation:\/\/a183898c-b718-4862-b437-a17dda5459a3\" alt=\"EXOSEAL being deployed at femoral groin access site in hybrid OR\"\u003e\u003c\/p\u003e\u003cp\u003e\u003cimg src=\"generation:\/\/4b04c71a-51ce-4794-ab92-6e6b363162b2\" alt=\"Macro close-up of bioabsorbable PGA plug matrix structure\"\u003e\u003c\/p\u003e\u003ch2\u003eDevice Specs\u003c\/h2\u003e\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eField\u003c\/th\u003e\n\u003cth\u003eSpecification\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eClosure Mechanism\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFully extravascular bioabsorbable plug; no intraluminal components\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePlug Material\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePolyglycolic acid (PGA) — bioabsorbable polymer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompatible Sheath Sizes\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5Fr, 6Fr, 7Fr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResorption Timeline\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eComplete resorption within 60–90 days via hydrolysis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResorption Byproducts\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCO₂ and H₂O (metabolic byproducts); no permanent implant\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDeployment Steps\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e3-step deployment sequence; no sutures, no metal clips\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Cordis","offers":[{"title":"Default Title","offer_id":46600175648967,"sku":null,"price":685.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0785\/3427\/9367\/files\/image_5f27f9ed-3d49-4109-a2c9-57a77447c600.png?v=1779870242","url":"https:\/\/medalliancellc.com\/products\/exoseal-vascular-closure-device","provider":"Medalliance LLC","version":"1.0","type":"link"}